New York Conf Page Header


World Health Organization

Topic Description

Plastics and health

Plastic has become an important part of modern life, helping make many products across diverse sectors more affordable, durable, and accessible. It also plays an essential role in healthcare through medical devices, protective equipment and medicine packaging. While plastic pollution has long been viewed primarily as an environmental issue, growing plastic production and waste have intensified concerns about its impacts on human health. In 2023, The World Health Assembly (WHA) expressed concern that “the production, consumption and disposal of plastic products, including microplastics and related chemicals, which can be released to the environment, may potentially impact human, plant and animal health as well as the environment, directly or indirectly” (WHA Resolution 76.17).

The World Health Organization (WHO) has noted that health risks can arise throughout the plastic lifecycle. Producing plastics can expose workers and nearby communities to hazardous substances. Chemicals used in or associated with some plastic products may enter food, water or the human body. Plastic waste can release harmful pollutants when it is openly burned or improperly managed. As plastics break down, they can also form microplastics and nanoplastics, which have been detected in air, water, food and the human body.

An important but less visible source of exposure is synthetic textiles. Many clothes, carpets and furnishings contain plastic-based materials such as polyester, nylon, acrylic and spandex. Tiny fibers can break away as these materials are worn, used and washed, releasing microfibers into wastewater and the air. UNEP estimates that synthetic textiles account for 16–35 percent of marine microplastic pollution and notes that textiles shed microplastics when they are both washed and worn. Studies have also found substantial quantities of synthetic fibers in indoor air and household dust, meaning that people may be exposed through breathing or ingesting dust.

Scientific evidence points to a wide range of ways that plastics and substances associated with them may affect human health. Some chemicals associated with plastics are known or suspected to cause harmful health effects, including effects on hormones and reproduction. Scientists are also studying possible links between microplastic and nanoplastic exposure and inflammation, cardiovascular and other health effects, but important questions remain about the levels of exposure that pose significant risks. WHO is continuing to assess what these exposures may mean for human health and has identified important gaps in knowledge about which types, sizes and levels of microplastics pose the greatest risks. Governments must therefore decide how to protect public health while scientific knowledge continues to evolve.

People’s exposure to plastics and their possible health impacts can differ depending on the products they use, the jobs they have, where they live and their age or stage of development. Workers in plastic production, recycling and waste management may face higher exposures, while communities living near production facilities, landfills or waste-burning sites can face additional risks. Where plastic waste is openly burned or improperly incinerated, hazardous chemicals and particles can be released into the air, exposing workers and nearby communities through the air they breathe. Exposure during pregnancy, infancy and childhood may be of particular concern because these are important stages of human development. Low- and middle-income countries may face growing plastic-waste burdens while having fewer resources for safe waste management, health monitoring and regulation.

In addition to addressing health risks posed by plastics across its lifecycle, it is important to recognize that many medical products depend on plastics because they can be used to produce sterile, durable and affordable healthcare products. WHO does not support simply exempting the entire healthcare sector from efforts to reduce plastic pollution. Instead, it supports reducing unnecessary plastic use while allowing special consideration for medicines and health products when safe and clinically effective alternatives are not yet available. Countries must therefore distinguish between plastic uses that can be safely reduced or replaced and the essential uses of plastics for which suitable alternatives may not yet exist, particularly in low-resource healthcare settings.

Delegates should consider:

  • How should countries make policy decisions when scientific evidence on the health impacts of plastics is still developing? Should they take precautionary action based on emerging evidence, or wait for a stronger scientific consensus before adopting new regulations? How can healthcare systems reduce unnecessary plastic use without compromising patient safety or access to essential products?
  • How can exposure hazardous plastic-associated chemicals and microplastics be reduced throughout the plastics lifecycle?
  • How can workers and communities facing higher exposure to plastics throughout it lifecycle be protected?

The challenge is to protect human health throughout the plastic lifecycle while recognizing both the benefits plastics provide within the healthcare system and the health risks that their production, use and disposal may create.

Join our mailing list!

Sign up form for WIMUN pages

Or stay up to date with the latest Global Model news by following us on social media!